$7.61
-2.27-22.98%
Last update: Nov 4, 6:37 PM

The average analyst price target for Kura Oncology is $24.50, 221.5% above the current price. Of 17 analysts, 14 rate it Buy and 3 Hold. Targets range from $10 to $40. The latest change came on Oct 1, 2026, when JP Morgan initiated coverage of Kura Oncology with an Overweight rating and a $30 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months